Global Biosurgery Market Size Reaches $16.9 Billion in 2025 with 7.7% CAGR

Global biosurgery market was valued at $16.9 billion in 2025 and is growing at a CAGR of 7.7% during the forecast period (2026-2035). Orthopedic surgery plays an essential role in biosurgery through the use of biologically derived materials and techniques that support tissue repair, healing, and regeneration of the musculoskeletal system. In procedures involving bone fractures, joint reconstruction, and soft tissue injuries, biosurgical solutions help manage bleeding, promote bone growth, and enhance wound healing. These approaches support improved surgical outcomes by reducing complications, supporting structural stability, and enabling faster recovery. The integration of biosurgery in orthopedic procedures also aligns with the growing focus on minimally invasive techniques, precision surgery, and improved postoperative care within modern orthopedic practice.

Browse the full report description of “Biosurgery Market Size, Share & Trends Analysis By Product Type (Bone-Graft Substitutes, Hemostatic Agents, Surgical Sealants & Adhesives, Adhesion Barriers, Soft-Tissue Attachments, Staple-Line Reinforcement, and Others), By Application (Orthopedic Surgery, General Surgery, Neurological Surgery, Cardiovascular Surgery, Gynecological Surgery, and Thoracic & Reconstructive Surgery), and by End-User (Hospitals & clinics, Ambulatory Surgical Centers (ASCs), and Others) Forecast Period (2026-2035)” at https://www.omrglobal.com/industry-reports/biosurgery-market

Moreover, global demand for orthopedic surgeries is increasing due to aging populations and higher rates of musculoskeletal disorders, sports injuries, and trauma, resulting in a greater need for biosurgical materials and fostering market growth. For instance, in September 2025, OSSIOfiber is a revolutionary bio-integrative non-metal implant designed for orthopedic surgery, promoting natural healing by being gradually replaced by the patient's own bone over 18-24 months. This innovative technology offers a safer alternative to traditional metal implants, which can cause pain, irritation, and require removal surgeries. Engineered from biocompatible minerals found in bone, OSSIOfiber provides stable fixation and eliminates the complications associated with permanent metal implants, enhancing the overall patient experience in orthopedic procedures.

Leading Participants Supporting Advancements in the Biosurgery Market

The key players in the biosurgery market include Baxter International Inc., Becton, Dickinson and Co., Braun Melsungen AG, Johnson Services, Inc., Integra LifeSciences Holdings Corp., among others. These companies are driving innovation in digital health solutions such as telemedicine, electronic health records, remote patient monitoring, and AI-powered clinical tools, shaping the future of healthcare delivery globally.

• In March 2025, Johnson & Johnson MedTech showcased its latest advancements in digital orthopaedics at the AAOS 2025 Annual Meeting, continuing from last year’s achievements with 18 FDA clearances and 45 global product launches. Innovations on display include the VELYS Robotic-Assisted Solution for knee replacements, improving precision and reducing revision risks; the KINCISE 2 Surgical Automated System to ease physical demands on surgeons; the VELYS Active Robotic Assistance for complex spine procedures; and the VOLT Trauma System, featuring dynamic compression technology. Additional products include the INHANCE INTACT system for shoulder replacements that allows immediate post-operative movement, and an AI-powered Advance Case Management system to enhance efficiency in surgical centers. Moreover, the combined use of STRATAFIX and DERMABOND PRINEO offers superior wound closure and patient satisfaction in joint arthroplasty.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Product Type
  • By Application
  • By End-User
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape -
• Baxter International Inc., Becton, Dickinson and Co., Braun Melsungen AG, Johnson Services, Inc., Integra LifeSciences Holdings Corp., among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Biosurgery Market Report Segment

By Product Type

• Bone-Graft Substitutes
• Hemostatic Agents
• Surgical Sealants & Adhesives
• Adhesion Barriers
• Soft-Tissue Attachments
• Staple-Line Reinforcement
• Others

By Application

• Orthopedic Surgery
• General Surgery
• Neurological Surgery
• Cardiovascular Surgery
• Gynecological Surgery
• Thoracic & Reconstructive Surgery

By End-User

• Hospitals & clinics
• Ambulatory Surgical Centers (ASCs)
• Others

Global Biosurgery Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/biosurgery-market